Free Trial

Chromocell Therapeutics (CHRO) Stock Chart & Stock Price History

$0.62 +0.08 (+14.84%)
(As of 11/20/2024 ET)

Chromocell Therapeutics Stock Price Performance

5 Day
Performance
-5.87%
1 Month
Performance
-10.97%
3 Month
Performance
-24.50%
6 Month
Performance
-65.98%
Receive CHRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CHRO Stock Chart for Thursday, November, 21, 2024

Chromocell Therapeutics Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
11/19/2024$0.63$0.56
-11.44%
$0.64$0.4647,980 shs$3.36 million
11/18/2024$0.63$0.63
-0.16%
$0.65$0.6314,738 shs$3.80 million
11/15/2024$0.63$0.66
+4.20%
$0.69$0.6312,054 shs$3.80 million
11/14/2024$0.64$0.63
-1.51%
$0.66$0.6341,142 shs$3.64 million
11/13/2024$0.64$0.64
+0.83%
$0.66$0.6418,034 shs$3.70 million
11/12/2024$0.68$0.64
-6.51%
$0.68$0.6313,460 shs$3.67 million
11/11/2024$0.66$0.68
+3.42%
$0.69$0.6332,694 shs$3.92 million
11/08/2024$0.64$0.66
+2.73%
$0.69$0.637,774 shs$3.79 million
11/07/2024$0.62$0.64
+3.19%
$0.67$0.6232,614 shs$3.69 million
11/06/2024$0.64$0.62
-3.64%
$0.67$0.6248,076 shs$3.58 million
11/05/2024$0.65$0.64
-0.98%
$0.64$0.6128,256 shs$3.71 million
11/04/2024$0.64$0.65
+1.25%
$0.65$0.6219,130 shs$3.75 million
11/01/2024$0.62$0.62
+0.27%
$0.69$0.6228,960 shs$3.59 million
10/31/2024$0.66$0.62
-5.83%
$0.70$0.6250,998 shs$3.58 million
10/30/2024$0.64$0.66
+2.76%
$0.66$0.6036,485 shs$3.80 million
10/29/2024$0.60$0.64
+6.80%
$0.71$0.60154,847 shs$3.70 million
10/28/2024$0.67$0.60
-10.42%
$0.72$0.60135,680 shs$3.46 million
10/25/2024$0.76$0.68
-10.13%
$0.76$0.63223,540 shs$3.94 million
10/24/2024$0.67$0.76
+13.43%
$0.93$0.63958,846 shs$4.38 million
10/23/2024$0.71$0.67
-5.63%
$0.70$0.6534,588 shs$3.86 million
10/22/2024$0.68$0.71
+4.41%
$0.75$0.6819,189 shs$4.10 million
10/21/2024$0.70$0.68
-2.23%
$0.73$0.6574,772 shs$3.92 million


This page (NYSE:CHRO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners